1.Short latency afferent inhibition in schizophrenia patients
Masaru Shoyama ; Shun Takahashi ; Tadahiro Hashimoto ; Tomikimi Tsuji ; Satoshi Ukai ; Kazuhiro Shinosaki
ASEAN Journal of Psychiatry 2013;14(2):1-8
The objective of this study was to test our preliminary in vivo evaluations of central cholinergic abnormalities in schizophrenia patients. Short latency afferent
inhibition (SAI) is based on coupling peripheral nerve stimulation with motor cortex Transcranial Magnetic Stimulation (TMS), which has been shown to be a putative
marker of central cholinergic activity. Methods: We evaluated SAI in 5 patients with schizophrenia and 5 healthy subjects. Results: The level of SAI was significantly lower in the patients with schizophrenia than in the controls (p=0.008). Conclusion:
Our findings suggest involvement of central cholinergic neurotransmission in schizophrenia, which indicates a possible approach for treatment of cognitive
dysfunction related to the disease.
2.The efficacy of a novel integrated outside biliary stent and nasobiliary drainage catheter system for acute cholangitis: a single center pilot study
Naosuke KURAOKA ; Tetsuro UJIHARA ; Hiromi KASAHARA ; Yuto SUZUKI ; Shun SAKAI ; Satoru HASHIMOTO
Clinical Endoscopy 2023;56(6):795-801
Background/Aims:
Endoscopic biliary drainage is the gold standard treatment for cholangitis. The two methods of biliary drainage are endoscopic biliary stenting and nasobiliary drainage. A novel integrated outside biliary stent and nasobiliary drainage catheter system (UMIDAS NB stent; Olympus Medical Systems) was recently developed. In this study, we evaluated the efficacy of this stent in the treatment of cholangitis caused by common bile duct stones or distal bile duct strictures.
Methods:
We conducted a retrospective pilot study by examining the medical records of patients who required endoscopic biliary drainage for cholangitis due to common bile duct stones or distal bile duct strictures, and who were treated with a UMIDAS NB stent, between December 2021 and July 2022.
Results:
Records of 54 consecutive patients were reviewed. Technical and clinical success rates were 47/54 (87.0%) and 52/54 (96.3%), respectively. Adverse events were observed in 12 patients, with six patients experiencing pancreatitis as an adverse event, following endoscopic retrograde cholangiopancreatography (ERCP). Regarding late adverse events, five cases of biliary stent migration into the bile duct were observed. Disease-related death occurred in one patient.
Conclusions
The outside-type UMIDAS NB stent is an efficacious new method for biliary drainage and can be applied to many indications.
3.A case report with the coincidental complication of paroxysmal atrial fibrillation in the course of methadone administration due to cancer pain
Yoshinobu Matsuda ; Yoshito Yoshikawa ; Sachiko Okayama ; Rie Hiyoshi ; Kaori Tohno ; Momoyo Hashimoto ; Hideki Noma ; Mamoru Ohnishi ; Takayasu Itakura ; Sachiko Kimura ; Shun Kohsaka
Palliative Care Research 2016;11(1):501-505
Introduction: Paroxysmal atrial fibrillation (Paf) occurred in an inpatient who has been prescribed methadone for cancer pain in our palliative care unit, but oral administration of aprindine (antiarrhythmic agent) succeeded in defibrillation and methadone administration could be continued. Case: A 75-year-old man had developed multiple bone metastases after resection of thyroid cancer. Due to refractory cancer pain, switching from oxycodone to methadone was performed. Pain relief was achieved with methadone 40 mg/day and without QT interval prolongation. After methadone administration about 9 months, there suddenly became loss of appetite in the morning of one day. ECG examination revealed Paf onset. Aprindine 20 mg was orally administered for the purpose of defibrillation. After about 2 hours sinus rhythm was gained and later without recurrence. Conclusion: This case was considered to have the coincidental complication of paroxysmal atrial fibrillation in the course of methadone administration. If administration of antiarrhythmic agents is performed in a patient whom has been prescribed methadone, it is feared to lead to result in QT interval prolongation due to drug interactions. It is important to carefully select an agent that rarely leads to QT prolongation.
4.Comparison of sweating components during endurance exercise under the same load in a hot environment and in a neutral thermal environment
Shun HASHIMOTO ; Narumi YAMASHITA ; Kosuke TANIGUCHI ; Masaaki SUGITA
Japanese Journal of Physical Fitness and Sports Medicine 2022;71(4):333-343
Sweat contains electrolytes (minerals), therefore, it is necessary to consider its loss through sweat in the fluid replacement strategy in sports. The purpose of this study was to compare the concentration of components in sweat, such as electrolytes (minerals), when endurance exercise is performed in hot and neutral thermal environments. Eight men cycled for 60 min at 55% VO2peak under two envitonment conditions: a hot environment (WetBulb Globe Temperature (WBGT): 29.0±0.2℃; Heat) and a neutral thermal environment (WBGT: 20.5±0.2℃; Con). During exercise, sweat loss, core temperature, and heart rate (HR) were measured, and sweat from the chest, back, and thigh was collected. The core temperature, sweat loss, and HR increased significantly in Heat. The sweat electrolyte concentration was significantly higher in Heat than in Con only for Na. Regarding the amount of electrolyte loss from sweat, Na and K showed a significantly higher value than Con in Heat in comparison of each region, and the total loss amount of three regions in Cu also had a significantly higher value than Con in Heat. In addition, there was no difference in the concentration of Ca and Cu between the regions, but there was a significant difference in the amount of loss. It was concluded that even if there was no difference in the electrolyte concentration in sweat, the amount of electrolyte loss increased in K and Cu in a hot environment, and that there was a site difference in the amount of loss in Ca and Cu.